| ADAR | Adenosine deaminase acting on RNA |
| BLV | Bulevirtide |
| CHD | Chronic hepatitis D |
| EASL | European Association for the Study of the Liver |
| EMA | European Medicines Agency |
| HBV | Hepatitis B virus |
| HBcrAg | Hepatitis B core related antigen |
| HBeAg | Hepatitis B e antigen |
| HBsAg | Hepatitis B surface antigen |
| HCC | Hepatocellular carcinoma |
| HCV | Hepatitis C virus |
| HDAg | Hepatitis D antigen |
| L-HDAg | Hepatitis D large antigen |
| HDV | Hepatitis D virus |
| HGF | hepatocyte growth factor |
| NTCP | Sodium taurocholate co-transporting polypeptide |
| NF-κB | Nuclear factor kappa B |
| NUC | Nucleos(t)ide analogues |
| peg-IFN-α | Pegylated interferon-α |
| RNP | Ribonucleoprotein |
| RORA | RAR related orphan receptor A |
| S-HDAg | Hepatitis D small antigen |
| SjD | Sjögren’s disease |
| SRC | SRC Proto-Oncogene |
| SVPs | Subviral particles |